The WHO approved a Kenya-based pharma company to produce a crucial antimalarial drug locally, reducing reliance on imports from India and China.
Category
🗞
NewsTranscript
00:00 [ Music ]
00:20 >> Most government facilities doesn't offer the exact medication that is worth or doing away
00:27 with the sickness or the malaria parasite.
00:30 But in major case people opt to go to private facilities where they are going
00:36 to get faster medication and a quality medication.
00:39 But it is never pocket friendly.
00:41 [ Music ]
00:53 [ Foreign Language ]
01:04 [ Music ]
01:12 >> To increase self-sufficiency on the continent with the stamp of WHO approval,
01:19 it means that we are also internationally certified again as a quality manufacturer.
01:23 And because the continent's problem, malaria is one of the biggest challenges,
01:30 it will really help in lowering the dependency for imports as we saw during the COVID era
01:37 where whatever was being imported actually had huge supply disruptions.
01:44 And malaria is such a thing that if you don't get the right medicine at the right time,
01:48 we all know it can cause unnecessary deaths.
01:51 [ Music ]